Rigid Corset Immobilisation of Patients Suffering From Spondylodiscitis: Practice Assessment

NCT ID: NCT06489977

Last Updated: 2024-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our study is a survey of the current management of patients suffering from spondylodiscitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our main objective was to describe the use of rigid corsets to immobilise patients with spondylodiscitis in hospital, by asking doctors about their practices.

The secondary objectives are :

* To describe the use of rigid corsets to immobilise patients suffering from spondylodiscitis in hospital by asking paramedical staff about the way in which medical prescriptions were implemented and patients about their compliance.
* To measure the rate of satisfaction and understanding of patients treated with a corset.
* To detail the different ways in which doctors and paramedical staff manage patients hospitalised for spondylodiscitis, depending on their age, training, speciality and the department in which they work.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Management of Spondylodiscitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For patients:

* Patients aged over 18,
* Patients hospitalised at Clermont-Ferrand University Hospital with infectious spondylodiscitis,
* Patient willing to be interviewed.

For care workers:

\- Doctors, nurses or care assistants involved in the care of patients hospitalised with spondylodiscitis.

Exclusion Criteria

For patients :

* Minor patients,
* Patients wearing a corset for a non-infectious spinal pathology,
* Patient refusing to take part in the study.

For care workers:

\- Doctor, nurse or nursing auxiliary refusing to take part in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aurore MIGNE

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Orlane MENAGE

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Clémence RICHAUD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Clermont Ferrand

Clermont-Ferrand, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lise LACLAUTRE

Role: CONTACT

334.73.754.963

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Delphine MARTINEAU, Mrs

Role: primary

+33473754992

Eman BA HARETHA, Mrs

Role: backup

+33473754992

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M24RC0512

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.